Safety and Efficacy of VDMN-21 Patch in Subjects With Common Warts
Study sponsor: Veradermics, Inc. · MANE
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2025-02-25Actual
Enrollment · participants153Actual
Source updated2025-05-08Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.